U2E-25634-11703
3 vaccinations
4 coded responses
18 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 027 / MA
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 1 — Pfizer-BioNTech
- 2021-01-19
- 2021-01-22
-
2021-01-23
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: Good · Headache · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Slight shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-02
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-16
-
2021-02-23
Survey response — day 14, dose 2MedDRA: Oropharyngeal pain, Paranasal sinus discomfort — Feeling: FairFree text: Sinus pressure and sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-04-02
-
2021-05-11
Survey response — 3 months, dose 2MedDRA: Dizziness — Feeling: GoodFree text: Lightheadedness around menstruationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-10
-
2021-12-05
Dose 3 — Pfizer-BioNTech
- 2022-02-09
- 2022-06-05
-
2022-12-05
Survey response — 12 months, dose 3MedDRA: Pre-eclampsia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: PreeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-12-05
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-12-06
- 2022-12-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech | |
| 3 | 2021-12-05 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Slight shortness of breath
Release 4 — day 14, dose 2
Symptoms: Sinus pressure and sore throat
Release 8 — 3 months, dose 2
Symptoms: Lightheadedness around menstruation
Release 12 — 12 months, dose 3
Symptoms: Preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release